Medical and Pharmaceutical Imperial College and Pancreatic Cancer UK begin 6,000 patient breath test study Pancreatic cancer remains one of the deadliest cancers in the UK Joseph MortonDecember 9, 2025
Medical and Pharmaceutical BioMark Diagnostics receives Innovation Award for lung cancer screening project It acknowledges the company’s development of an efficacious blood biopsy Rowan DunneDecember 3, 2025
Medical and Pharmaceutical BioMark Diagnostics ships liquid biopsy tech to Germany for 10,000-person lung cancer study 'HANSE' is the nation's largest lung cancer trial of all time Rowan DunneNovember 13, 2025
Medical and Pharmaceutical SmartPath Uses AI to personalize cancer care across Asia SmartPath was trained using over 500,000 whole slide images covering 34 major tissue sites Joseph MortonOctober 23, 2025
Medical and Pharmaceutical Evaxion shares spike as AI-designed melanoma vaccine data hits market The presentation will include information on the breadth, magnitude, and duration of T-cell responses following booster immunization Joseph MortonOctober 15, 2025
Medical and Pharmaceutical Guardant Health backs lung cancer screening advocacy campaign The aim is to enhance public understanding about proper screening and biomarker testing diligence Rowan DunneSeptember 30, 2025
Medical and Pharmaceutical McMaster surgeon develops AI tool to reduce invasive lung biopsies The technology uses an AI model trained on thousands of ultrasound scans Joseph MortonSeptember 25, 2025
Medical and Pharmaceutical University of Warwick uses diamonds to help trace metastasis in cancer The Warwick team designed a highly sensitive sensor using a diamond measuring just half a cubic millimetre Joseph MortonAugust 22, 2025
Medical and Pharmaceutical Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test The FDA grants Breakthrough Device designation to devices that may offer more effective treatment or diagnosis of serious conditions like cancer Joseph MortonJune 24, 2025
Medical and Pharmaceutical Australian biotech uncovers broader view of tumour genetics with liquid biopsy The team developed the study in collaboration with US sequencing company Illumina Joseph MortonJune 17, 2025